FLT3 and acute myeloid leukemia: Internal tandem duplication of FLT3 (FLT3-ITD) within the juxtamembrane domain and point mutation in kinase domain (e.g., D835Y) are representative mutations present in AML patients, resulting in constitutive activation of kinase activity [6,8].